THE SECURITIES
EVIDENCED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE U.S.
SECURITIES ACT OF 1933, AS AMENDED (THE “ SECURITIES
ACT ”), OR ANY OTHER APPLICABLE SECURITIES LAWS AND HAVE
BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER SECURITIES LAWS.
NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY
BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED,
HYPOTHECATED OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR ANY
OTHER APPLICABLE SECURITIES LAWS, OR PURSUANT TO A TRANSACTION
WHICH IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH
REGISTRATION.
Warrant to
Purchase up to 400,000 shares of Common Stock of EPIX
Pharmaceuticals, Inc. (the “ Company
”).
In consideration
for Kingsbridge Capital Limited (the “ Investor
”) agreeing to enter into that certain Common Stock Purchase
Agreement, dated as of the date hereof, between the Investor and
the Company (the “ Agreement ”), the Company
hereby agrees that the Investor or any other Warrant Holder (as
defined below) is entitled, on the terms and conditions set forth
below, to purchase from the Company at any time during the Exercise
Period (as defined below) up to 400,000 fully paid and
non-assessable shares of common stock, par value $0.01 per share,
of the Company (the “ Common Stock ”) at the
Exercise Price (as defined below), as the same may be adjusted from
time to time pursuant to Section 6 hereof. The resale of the
shares of Common Stock or other securities issuable upon exercise
or exchange of this Warrant is subject to the provisions of the
Registration Rights Agreement. Capitalized terms used herein and
not otherwise defined shall have the meanings given them in the
Agreement.
“
Affiliate ” shall mean any Person that, directly or
indirectly through one or more intermediaries, controls or is
controlled by, or is under direct or indirect common control with
any other Person. For the purposes of this definition, “
control ,” when used with respect to any Person, means
the power to direct the management and policies of such Person,
directly or indirectly through the ownership of voting securities,
and the term “ controls ” and “
controlled ” have meanings correlative to the
foregoing.
“
Closing Price ” as of any particular day shall mean
the closing price per share of the Company’s Common Stock as
reported by Bloomberg L.P. on such day.
“
Exercise Period ” shall mean that period beginning six
months after the date of this Warrant and continuing until the
earlier of (i) the expiration of the five-year period
thereafter, or (ii) a Funding Default, subject in each case to
earlier termination in accordance with Section 6
hereof.
“
Exercise Price ” as of the date hereof shall mean
$2.4925.
“
Funding Default ” shall mean a failure by Investor to
accept a Draw Down Notice made by the Company and to acquire and
pay for the Shares in accordance therewith within three (3) Trading
Days following the delivery of such Shares to the Investor,
provided such Draw Down Notice was made in accordance with the
terms and conditions of the Agreement (including the satisfaction
or waiver of the conditions to the obligation of the Investor to
accept a Draw Down set forth in Article VII of the Agreement),
provided further, that such failure was reasonably within the
control of the Investor.
“
Per Share Warrant Value ” shall mean the difference
resulting from subtracting the Exercise Price from the Closing
Price on the Trading Day immediately preceding the Exercise
Date.
“
Person ” shall mean an individual, a corporation, a
partnership, a limited liability company, an association, a trust
or other entity or organization, including a government or
political subdivision or an agency or instrumentality
thereof.
“
Principal Market ” shall mean the NASDAQ Global Select
Market, the NASDAQ Global Market, the NASDAQ Capital Market, the
American Stock Exchange or the New York Stock Exchange, whichever
is at the time the principal trading exchange or market for the
Common Stock.
“
SEC ” shall mean the United States Securities and
Exchange Commission.
“
Trading Day ” shall mean any day other than a Saturday
or a Sunday on which the Principal Market is open for trading in
equity securities.
“
Warrant Holder ” shall mean the Investor or any
permitted assignee or permitted transferee of all or any portion of
this Warrant.
“
Warrant Shares ” shall mean those shares of Common
Stock received upon exercise of this Warrant.
(a)
Method of Exercise . This Warrant may be exercised in whole
or in part (but not as to a fractional share of Common Stock), at
any time and from time to time during the Exercise Period, by the
Warrant Holder by surrender of this Warrant, with the form of
exercise attached hereto as Exhibit A completed and
duly executed by the Warrant Holder (the “ Exercise
Notice ”), to the Company at the address set forth in
Section 10.4 of the Agreement, accompanied by payment of the
Exercise Price multiplied by the number of shares of Common Stock
for which this Warrant is being exercised (the “ Aggregate
Exercise Price ”). The later of the date on which an
Exercise Notice or payment of the Exercise Price (unless this
Warrant is exercised in accordance with Section 2(c) below) is
received by the Company in accordance with this clause
(a) shall be deemed an “ Exercise Date
.”
(b)
Payment of Aggregate Exercise Price . Subject to paragraph
(c) below, payment of the Aggregate Exercise Price shall be
made by wire transfer of immediately available funds to an account
designated by the Company. If the amount of the payment received by
the Company is less than the Aggregate Exercise Price, the Warrant
Holder will be notified of the deficiency and shall make payment in
that amount within three (3) Trading Days. In the event the
payment exceeds the Aggregate Exercise Price, the Company will
refund the excess to the Warrant Holder within five (5) Trading
Days of receipt.
(c)
Cashless Exercise . In the event that the Warrant Shares to
be received by the Warrant Holder upon exercise of the Warrant may
not be resold pursuant to an effective registration statement or an
exemption to the registration requirements of the Securities Act
and applicable state laws, the Warrant Holder may, as an
alternative to payment of the Aggregate Exercise Price upon
exercise in accordance with paragraph (b) above, elect to
effect a cashless exercise by so indicating on the Exercise Notice
and including a calculation of the number of shares of Common Stock
to be issued upon such exercise in accordance with the terms hereof
(a “ Cashless Exercise ”). If a registration
statement on Form S-3 under the Securities Act or such other form
as deemed appropriate by counsel to the Company for the
registration for the resale by the Warrant Holder of (x) the
shares of Common Stock of the Company that may be purchased under
the Agreement, (y) the Warrant Shares, or (z) any
securities issued or issuable with respect to any of the foregoing
by way of exchange, stock dividend or stock split or in connection
with a combination of shares, recapitalization, merger,
consolidation or other reorganization or otherwise, has been
declared effective by the SEC and remains effective, the Company
may, in its sole discretion, permit the Warrant Holder to effect a
Cashless Exercise or require the Warrant Holder to pay the Exercise
Price of the Warrant Shares being purchased by the Warrant Holder
under this Warrant. In the event of a Cashless Exercise, the
Warrant Holder shall receive that number of shares of Common Stock
determined by (i) multiplying the number of Warrant Shares for
which this Warrant is being exercised by the Per Share Warrant
Value and (ii) dividing the product by the Closing Price on
the Trading Day immediately preceding the Exercise Date, rounded to
the nearest whole share. The Company shall cancel the total number
of Warrant Shares equal to the excess of the number of the Warrant
Shares for which this Warrant is being exercised over the number of
Warrant Shares to be received by the Warrant Holder pursuant to
such Cashless Exercise.
(d)
Replacement Warrant . In the event that the Warrant is not
exercised in full, the number of Warrant Shares shall be reduced by
the number of such Warrant Shares for which this Warrant is
exercised, and the Company, at its expense, shall forthwith issue
and deliver to or upon the order of the Warrant Holder a new
Warrant of like tenor in the name of the Warrant Holder, reflecting
such adjusted number of Warrant Shares.
Section 3.
Ten Percent Limitation . The Warrant Holder may not exercise
this Warrant such that the number of Warrant Shares to be received
pursuant to such exercise aggregated with all other shares of
Common Stock that are then beneficially owned or deemed to be
beneficially owned by the Warrant Holder would result in the
Warrant Holder owning more than 9.9% of all of such Common Stock as
would be outstanding on such Exercise Date, as determined in
accordance with Section 13(d) of the Exchange Act.
Section 4.
Delivery of Warrant Shares .
(a) Subject
to the terms and conditions of this Warrant, as soon as practicable
after the exercise of this Warrant in full or in part, and in any
event within ten (10) Trading Days thereafter, the Company at
its expense (including, without limitation, the payment by it of
any applicable issue taxes) will cause to be issued in the name of
and delivered to the Warrant Holder, or as the Warrant Holder may
lawfully direct, a certificate or certificates for, or make deposit
with the Depositary Trust Company via book-entry of, the number of
validly issued, fully paid and non-assessable Warrant Shares to
which the Warrant Holder shall be entitled on such exercise,
together with any other stock or other securities or property
(including cash, where applicable) to which the Warrant Holder is
entitled upon such exercise in accordance with the provisions
hereof.
(b) This
Warrant may not be exercised as to fractional shares of Common
Stock. In the event that the exercise of this Warrant, in full or
in part, would result in the issuance of any fractional share of
Common Stock, then in such event the Warrant Holder shall receive
the number of shares rounded down to the nearest whole
share.
Section 5.
Representations, Warranties and Covenants of the Company
.
(a) The
Warrant Shares, when issued in accordance with the terms hereof,
will be duly authorized and, when paid for or issued in accordance
with the terms hereof, shall be validly issued, fully paid and
non-assessable.
(b) The
Company shall take all commercially reasonable action and
proceedings as may be required and permitted by applicable law,
rule and regulation for the legal and valid issuance of this
Warrant and the Warrant Shares to the Warrant Holder.
(c) The
Company has authorized and reserved for issuance to the Warrant
Holder the requisite number of shares of Common Stock to be issued
pursuant to this Warrant. The Company shall at all times reserve
and keep available, solely for issuance and delivery as Warrant
Shares hereunder, such shares of Common Stock as shall from time to
time be issuable as Warrant Shares.
(d) From
the date hereof through the last date on which this Warrant is
exercisable, the Company shall take all steps commercially
reasonable to ensure that the Common Stock remains listed or quoted
on the Principal Market.
Section 6.
Adjustment of the Exercise Price . The Exercise Price and,
accordingly, the number of Warrant Shares issuable upon exercise of
the Warrant, shall be subject to adjustment from time to time upon
the happening of certain events as follows:
(a)
Reclassification, Consolidation, Merger, Mandatory Share
Exchange, Sale or Transfer .
(i) Upon
occurrence of any of the events specified in subsection (a)(ii)
below (the “ Adjustment Events ”) while this
Warrant is unexpired and not exercised in full, the Warrant Holder
may in its sole discretion require the Company, or any successor or
purchasing corporation, as the case may be, without payment of any
additional consideration therefor, upon surrender by the Warrant
Holder of the Warrant to be replaced, to execute and deliver to the
Warrant Holder a new Warrant providing that the Warrant Holder
shall have the right to exercise such new Warrant (upon terms not
less favorable to the Warrant Holder than those then applicable to
this Warrant) and to receive upon such exercise, in lieu of each
share of Common Stock theretofore issuable upon exercise of this
Warrant, the kind and amount of shares of stock, other securities,
money or property receivable upon such Adjustment Event by the
holder of one share of Common Stock issuable upon exercise of this
Warrant had this Warrant been exercised immediately prior to such
Adjustment Event. Such new Warrant shall provide for adjustments
that shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Section 6.
(ii) The
Adjustment Events shall be (1) any reclassification or change
of Common Stock (other than a change in par value, as a result of a
subdivision or combination of Common Stock or in connection with an
Excluded Merger or Sale), (2) any consolidation, merger or
mandatory share exchange of the Company with or into another
corporation (other than a merger or mandatory share exchange with
another corporation in which the Company is a continuing
corporation and whi
|